SI
IONS icon

Stephens Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Stephens Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.4K Buy
+26,761
New +$2.11M ﹤0.01% 1251
2024
Q3 		– Sell
-5,138
Closed -$245K – 1319
2024
Q2 		$245K Sell
5,138
-2,715
-35% -$111K ﹤0.01% 1084
2024
Q1 		$340K Sell
7,853
-102
-1% -$4.86K 0.01% 959
2023
Q4 		$402K Buy
7,955
+470
+6% +$22.5K 0.01% 830
2023
Q3 		$340K Sell
7,485
-21
-0.3% -$866 0.01% 865
2023
Q2 		$308K Buy
7,506
+164
+2% +$6.3K 0.01% 904
2023
Q1 		$262K Buy
7,342
+339
+5% +$12.7K 0.01% 935
2022
Q4 		$265K Sell
7,003
-2,122
-23% -$89.3K 0.01% 899
2022
Q3 		$404K Sell
9,125
-2,519
-22% -$106K 0.01% 780
2022
Q2 		$431K Sell
11,644
-908
-7% -$34.2K 0.01% 775
2022
Q1 		$465K Sell
12,552
-5,149
-29% -$169K 0.01% 839
2021
Q4 		$539K Sell
17,701
-3,440
-16% -$108K 0.01% 825
2021
Q3 		$709K Sell
21,141
-4,497
-18% -$169K 0.01% 749
2021
Q2 		$1.02M Buy
25,638
+482
+2% +$18.9K 0.02% 654
2021
Q1 		$1.13M Sell
25,156
-953
-4% -$53.1K 0.02% 588
2020
Q4 		$1.48M Buy
26,109
+4,711
+22% +$235K 0.03% 494
2020
Q3 		$1.01M Sell
21,398
-230
-1% -$12.8K 0.02% 551
2020
Q2 		$1.27M Sell
21,628
-683
-3% -$38K 0.03% 459
2020
Q1 		$1.05M Sell
22,311
-728
-3% -$40.6K 0.03% 456
2019
Q4 		$1.39M Buy
23,039
+1,170
+5% +$69.7K 0.03% 478
2019
Q3 		$1.31M Sell
21,869
-525
-2% -$34.2K 0.03% 487
2019
Q2 		$1.44M Buy
22,394
+846
+4% +$59.8K 0.03% 474
2019
Q1 		$1.75M Sell
21,548
-803
-4% -$51.8K 0.04% 428
2018
Q4 		$1.21M Sell
22,351
-447
-2% -$22.8K 0.03% 473
2018
Q3 		$1.18M Buy
+22,798
New +$1.07M 0.03% 528

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stephens Inc's IONS Position: Q1 2026 in Review

Stephens Inc opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 26,761 shares worth $91.4K. The stake represents ﹤0.01% of the portfolio and ranks #1251 among its holdings. This is a return to the name: Stephens Inc previously reported a position in IONS as recently as Q2 2024.

Stephens Inc first reported a position in IONS in Q3 2018 and has held it in 25 quarters since. The position peaked at $1.75M in Q1 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Stephens Inc held 26,761 shares of Ionis Pharmaceuticals worth $91.4K as of Q1 2026.
  • Ionis Pharmaceuticals was a new Stephens Inc position in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Stephens Inc's portfolio in Q1 2026, its #1251 holding.
  • Stephens Inc first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 25 quarters since.
  • Stephens Inc's Ionis Pharmaceuticals position peaked at $1.75M in Q1 2019.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.